Manganese superoxide dismutase (MnSOD) is an antioxidant enzyme responsible for the elimination of superoxide radical. The role of MnSOD in tumor progression in different human cancers is still controversial. In the present study, MnSOD expression in lung cancer cells was explored by knockdown or overexpression using transfection of a small hairpin RNA or an expression vector, respectively, to determine whether MnSOD expression mediates lung cancer cell migration, invasion, and oncogenic potential by increasing FoxM1 and MMP2 expression. Western blotting showed that FoxM1 and MMP2 expression was dependent on MnSOD expression, suggesting that 
Introduction
The manganese-containing superoxide dismutase (MnSOD) is an important antioxidant enzyme that eliminates superoxide radical (O 2 -) by converting it into H 2 O 2 (1) . MnSOD may also function as a tumor suppressor; for example, it may reduce growth of tumors associated with melanoma (2), pancreatic adenocarcinoma (3, 4) , colorectal cancer (5), ovarian cancer (6), breast cancer (7), and multiple myeloma (8) .
Conversely, MnSOD may promote tumor progression in cancers such as fibrosarcoma (9) , gastric cancer (10, 11) , glioblastoma (12) , T cell lymphoma (13) , breast cancer (14, 15) , cervical cancer (16), prostate cancer (17), and lung cancer (18). Therefore, the precise role of MnSOD in tumorigenesis remains elusive.
FoxM1, a member of the forkhead box transcription factor family, is only expressed in proliferating cells and is involved in cell-cycle progression (23). Several studies have implicated FoxM1 in tumorigenesis, as it is overexpressed in various human cancers including lung cancer (24-28). Kim et al. (2006) showed that proliferation of lung tumor cells was diminished in Mx-Cre FoxM1 -/-mouse mutants and that these mice had a significant reduction in the number and size of lung adenomas (28). In contrast, tumors from FoxM1-transgenic mice treated with 3-methylcholanthrene/butylated hydroxytoluene displayed a significant increase in number, size, and DNA replication compared to wildtype mouse tumors (28).
Conversely, lung tumor number and size were remarkably reduced when FoxM1 was deleted from mouse respiratory epithelial cells (epFoxM1 -/-grown in a 37 ºC humidified incubator in a 5% CO 2 atmosphere.
Quantitative real-time RT-PCR
The detail procedures were performed as described previously (32) .
Plasmid construction
A full-length human MnSOD cDNA was amplified from A549 mRNA by the reverse transcriptase-polymerase chain reaction (reverse transcriptase-PCR) using primers based on published mRNA sequences (GenBank: BC012423.1) as follows: sense oligonucleotide 5'-GAATTCATGTTGAGCCGGGCA-3', and antisense oligonucleotide 5'-GGATCCTTACTTTTTGCAAGCCATGTATCT -3'. The polymerase chain reaction product was cloned into the KpnI and
HindIII sites of the pGL3-Basic vector from A549. The resulting construct was confirmed by DNA sequencing. The 5'-flanking deletion constructs of the FoxM1 promoter, (-330/+26) FoxM1 and (-178/+26) FoxM1, were similarly generated using the (-600/+26) FoxM1 construct as a template (Supplementary   table 2) .
Soft-agar colony formation assay and Boyden chamber invasion assay
These assays were performed as described previously (33) . Luciferase assays were conducted using the luciferase reporter assay system (Promega, Madison, WI) 48 hours after transfection. Normalized luciferase activity was reported as luciferase activity/β-galactosidase activity.
Luciferase reporter assay
on
Site directed mutagenesis and transient transfection
Detailed procedures have been described previously (34) . Briefly, the expression plasmid was a derivative of pCDNA3 (Invitrogen, Carlsbad, CA) constructed by ligation of a 1192 bp EcoRI and XbaI fragment derived from pC53SN by the polymerase chain reaction (PCR). Primer A (5'-GGAATTCATGGAGGAGCCGCAG TCAGATCC-3') and primer B (5'-AGTCTAGATCAGTCTGAGTCAGGCCC -TTCTG-3') contained the entire wildtype p53 (WT-p53) coding sequence in frame and these were used to insert the fragment into the EcoRI/XbaI sites of pCDNA3.1.
The nucleotide sequences and amino acid substitutions of the mutated primers used for the construction of mutant recombinant P53 were 5'-GCATCGTATCCGA -GTGGAAGG-3' for L194R 5'-GAACCGGAGTCCCATCCTCAC-3' for R249S.
Constructs were verified by direct sequencing. The negative control plasmid containing no p53 was pcDNA3.1. The H1299 cells were seeded at 1×10 6 control expression plasmids were transiently transfected at different concentrations into H1299 cells. The Transfast reagent/plasmid mixture was then added directly to the cells, followed by incubation at 37 °C and 5% CO 2 for 2h. After 48 h, cells were harvested and whole cell and whole cell extracts were assayed in the following experiments.
Western blotting
Cells were washed twice on ice with PBS before adding protein lysis buffer (1× protease inhibitor cocktail, Roche, Basel, Switzerland, 1.5mM EDTA, 1mM DTT, 10% glycerol, 25mM HEPES, pH 7.6). The protein concentration was determined by the Bradford assay (BioRad, Hercules, CA) using BSA as a standard. Total protein (20μg) was resolved by 10% SDS-PAGE for subsequent Western blot analysis using antibodies against the following proteins (diluted in TTBS (Tween-Tris Buffered Saline: 0.02% Tween-20 in 100mM Tris-CL [pH 7.5]) as indicated): β-actin (1:100,000), MnSOD (1:1,000), FoxM1 (1:1,000), p21WAF-1(1:1,000), Rb (1:1,000), MMP1 (1:1000), MMP2 (1:1000), MMP2 (1:1000), MMP7 (1:1000), Sp1 (1:1000) and p53 (1:1,000). The gel was transferred to a Hybond-C Extra membrane the secondary antibody for detection using an ECL Western blot detection system.
Chromatin immunoprecipitation (ChIP) assays
ChIP analysis was performed according to a published procedure, with the following modifications (35) . Immunoprecipitated DNA was ethanol precipitated and resuspended in 20 μl ddH2O. Total input samples were resuspended in 100 μl ddH2O and diluted 1:100 before PCR analysis. PCR amplification of immunoprecipitated DNA was carried out with diluted aliquots using the oligonucleotides (5'-GGAGCAGAGGAGCCTGAG-3') and (5'-AAAAGTGGCCGTGGGGC -3') as primers, which encompass the 153-bp promoter region of FoxM1 (-350/198 ). The PCR products were separated on 2% agarose gels and analyzed by ethidium bromide staining. All ChIP assays were performed at least twice and produced similar results.
Cells were seeded at 1×10 6 cells in 6-cm dishes and incubated at 37 °C for 18 h. Cells were equally cotransfected with green fluorescent protein (GFP) and the MnSOD plasmids for 24 h.
Flow cytometry analysis
For flow cytometry analysis, cells (5 ×10 5 ) were seeded onto 6 cm dishes for 24 hours. 
Statistical analysis
Chi-square analysis was performed using SPSS software (Version 13.0 SPSS Inc., Chicago, IL) for statistical analysis. Statistical differences for survival data were analyzed using the log-rank test. Survival curves were plotted using the Kaplan-Meier method and variables related to survival were analyzed using Cox's proportional hazards regression model using SPSS software. A value of p < 0.05 was considered to be statistically significant.
Results

MnSOD is positively correlated with FoxM1 and MMP2 expression
The potential association of MnSOD with (Fig 1D) . These results supported a change in p21 expression due to MnSOD-knockdown and MnSOD-overexpression in both cell lines.
We also used p53 mutated H1355 and CL1-0 cell lines to investigate whether MnSOD could decrease Rb expression by increasing the release of E2F1 from the Rb-E2F1 complex and subsequent upregulation of FoxM1 expression. As shown in Figure 1E 
FoxM1 transcription is upregulated by MnSOD via increased binding activity of E2F1 and Sp1 onto the FoxM1 promoter
Previous studies indicated the existence of putative E2F1 binding sites on the FoxM1 promoter, and showed that FoxM1 transcription was decreased by E2F1-knockdown (36, 37). However, no evidence was presented to confirm E2F1 as a transcription factor of FoxM1. In the present study, three promoter regions of the FoxM1 gene (-600/+26, -330/+26 and -178/+26) were constructed, and three E2F1 and one Sp1 putative binding sites were detected on the -600/+26 promoter region using the software available at http://molsun1.cbrc.aist.go.jp/research/db/TFSEARCH.html ( Fig Luciferase reporter assay showed that the reporter activity of the -330/+26 promoter in p53-mutated or null cells accounted for ~80% of the reporter activity of the -600/+26 promoter. However, in p53-wildtype cells, the reporter activity of the -330/+26 promoter was decreased to ~50% of the reporter activity of the -600/+26
promoter. These findings indicated that the binding activity of E2F1 and Sp1 to the -330/+26 promoters could be deregulated by wildtype p53.
Chromatin immunoprecipitation (ChIP) assays indicated that the binding of E2F1 and Sp1 onto the -330/+26 promoter was not detectable in p53-wildtype A549 and H460 cells; however, the binding onto -330/+26 was always detected in p53-mutated or p53-null cells. The impact of wildtype or mutant p53 on FoxM1 transcription was further examined by transfecting H1299 cells with wildtype and mutant L194R and R249S p53. As expected, the reporter activity of the -330/+26 promoter was markedly decreased by transfection with wildtype p53; however, the reporter activity of the -330/+26 promoter was not changed by transfection with either mutant p53 when compared with their control cells (Fig. 2C) . The ChIP assay further revealed that the binding activity of E2F1 and Sp1 onto the -330/+26 promoter was significantly decreased by wildtype p53, but not by either mutant p53 (Fig. 2C) . The reporter activity of FoxM1 (-330/+26) was decreased by transfection with wildtype p53, but not by transfection with mutant p53 (L194R, R249S) in H1299 cells (Fig. 2D) . We 
MnSOD expression may independently predict survival and relapse in lung adenocarcinomas
We further evaluated the potential for an association between MnSOD expression and the outcome of patients with lung adenocarcinomas. We enrolled 101 patients for OS analysis, and of these, 89 were available for RFS analysis, with a median number of MnSOD-positive tumors versus those with MnSOD-negative tumors was 1.94 (95% CI, 1.17-3.21, P = 0.010; Table 2 ).
We also examined the influence of MMP2 mRNA on OS and RFS of these patients. In a Cox model for OS, poorer median survival and 5-year survival rate was observed in patients with high MMP2 mRNA than with low MMP2 mRNA (16 vs. 22 months for median survival; 21 vs. 48% for 5-year survival; HR, 2.17, 95% CI, 1.28-3.69; P = 0.004; Table 2 ). In a Cox model for RFS, the median survival and 5-year survival rate were marginally worse in patients with high MMP2 mRNA than with low MMP2 mRNA (14 vs. 18 months for median survival; 10% vs. 35% for 5-year survival; HR, 1.68, 95% CI, 1.00-2.80, P = 0.049; Table 2 
Discussion
In the present study, we provide evidence, from both in vitro cell studies and in vivo human lung tumors, to indicate that metastasis of lung adenocarcinoma is promoted by MnSOD and that the mechanism involves upregulation of the FoxM1-MMP2 axis.
Two putative E2F1 sites have previously been identified in the FoxM1 promoter, but direct activation of FoxM1 by E2F1 has not yet been demonstrated (36) . We showed that release of E2F1 from the Rb-E2F1 complex due to suppression of p53 and p21 expressions by MnSOD resulted in increased E2F1 binding to the FoxM1 promoter in MnSOD-overexpressing H460 cells (Fig. 2G upper panel) . The capability of Sp1 binding to FoxM1 promoter was also increased by suppression of p53 expression by MnSOD (Fig. 2G lower panel) . This was due to a derepression of Sp1 DNA binding activity by reduction of p53 expression by MnSOD (38, 39). Conversely, marked elevation of p53 and Rb expression, but reduced FoxM1 expression, was observed in MnSOD-knockdown A549 cells. However, FoxM1 expression was restored in A549 cells with a double knockdown of MnSOD and p53 expression (Fig. 2H upper panel) .
This restoration of FoxM1 expression was consistent with a decrease in Rb expression
and an increase in E2F1 and Sp1 binding to the FoxM1 promoter in A549 cells with double knockdown of MnSOD and p53 (Fig. 2H lower panel) . These results clearly A previous study showed that reduced levels of p21 and degradation of Rb might play a role in E2F1-mediated FoxM1 transcription (36) . Consistent with previous results, the expression of p21 and Rb was also remarkably decreased in MnSOD-knockdown lung cancer cells. We provided further evidence to show that the release of E2F1 from the Rb-E2F1 complex, which occurs due to decreased expression of p53 and Rb in response to MnSOD, might be involved in the upregulation of FoxM1 expression (Fig.   2G, 2H ). This observation speculation is supported by the fact that the number of cells in the G1-S transition was elevated in MnSOD-overexpressing CL1-0 cells and was reduced in MnSOD-knockdown H1355 cells (Fig. 1D) . Therefore, modulation of p21 
report showed that MMP2 transcription was directly upregulated by FoxM1 and that the invasion of glioma cells was enhanced by FoxM1-induced MMP2 expression (30).
In the present study, MMP2 expression was markedly decreased in FoxM1-knockdown cells (Fig. 3D) , but no change was seen for MnSOD expression (Supplementary figure 3A) . Moreover, FoxM1 and MMP2 expressions induced by MnSOD in lung cancer cells were responsible for an increase in cell invasion capability and enhanced potential for anchorage-independent colony growth (Fig. 3D) .
However, the enhancement of invasive and migratory activity of HT-1080 fibrosarcoma and 253J bladder cancer cells by MnSOD overexpression was mediated through MMP1. Our data indicated that MMP1 and MMP2 expression levels were concomitantly decreased in MnSOD-knockdown A549 cells, but no change was seen for MMP7 and MMP9 expressions (Supplementary figure 2B) , which suggests that MMP1 might partially contribute to MnSOD-induced cell invasiveness and oncogenic activity of lung cancer cells. A recent meta-analysis report indicated that MMP2 expression was associated with poorer prognosis in patients with lung adenocarcinoma (39). Similar findings reveal that MMP2 acts as a critical accelerator to the progression of lung adenocarcinoma (Table 2 ).
In summary, we provide mechanistic evidence to support the possibility that lung 
